The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Flebogamma DIF

Instituto Grifols S.A.EU/1/07/404/006-008

Main Information

Trade NameFlebogamma DIF
Active SubstancesHuman normal immunoglobulin
Dosage FormSolution for infusion
Licence HolderInstituto Grifols S.A.
Licence NumberEU/1/07/404/006-008

Group Information

ATC CodeJ06BA Immunoglobulins, normal human
J06BA02 immunoglobulins, normal human, for intravascular adm.


License statusAuthorised
Licence Issued
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back